Brainsway Ltd. BWAY
Brainsway Ltd. (Nasdaq: BWAY) is a CNS/neurology/psychiatry medical device company.
Upcoming catalysts
No catalyst is dated to the next 30 days or to an FDA action date.
Pipeline
| Program | Indication | Modality | Stage |
|---|---|---|---|
| Deep TMS system | MDD / anxious depression (510(k) cleared incl. accelerated protocol and adolescents 15-21) | device-combination | NA_NON_THERAPEUTIC |
| Deep TMS system | OCD (de novo classification) | device-combination | NA_NON_THERAPEUTIC |
| Deep TMS system | Smoking addiction (510(k)) | device-combination | NA_NON_THERAPEUTIC |
For subscribers
- Cash runway against each catalyst, with the company's own runway statement
- Track record: every Phase 3 readout, FDA decision and guidance slip since 2014
- Expected move for each dated catalyst, from comparable past events
- Phase 2 evidence behind each Phase 3 readout
- Companies on the same target or class
- Full catalyst list with filing sentences, deals, registered trials, Excel export
Other CNS/neurology/psychiatry companies
The free Monday brief
Last week's readouts and FDA decisions and the dated catalysts in the week ahead, each with its filing sentence.